Forex ziņas

Japanese Market Significantly Lower

Paring the gains in the previous session, the Japanese stock market is significantly lower on Tuesday, with the Nikkei 225 falling below the 32,500 level, despite the broadly positive cues from Wall Street overnight, with losses across most sectors, led by technology stocks. Financial stocks were the only bright spot.
RTTNews | 682 days ago
Sensex, Nifty Seen Lower On Weak Global Cues

Sensex, Nifty Seen Lower On Weak Global Cues

Indian shares are seen opening lower on Tuesday as worries mounted over China's property sector, the dollar reached its peak for the year and the U.S. bond market continued its four-week sell-off.
RTTNews | 682 days ago
Australian Market Notably Lower

Australian Market Notably Lower

After ending with slight gains in the previous two sessions, the Australian stock market is notably lower on Tuesday, with the benchmark S&P/ASX 200 staying below the 7,100 level, despite the broadly positive cues from Wall Street overnight, with weakness across most sectors led by mining and technology stocks. Traders also cautiously await domestic inflation data due on Wednesday.
RTTNews | 682 days ago
Dollar Climbs Higher On Interest Rate Bets

Dollar Climbs Higher On Interest Rate Bets

The U.S. dollar advanced against its major counterparts on Monday amid bets the Federal Reserve will keep interest rates higher for longer, and on concerns about the property market in China.
RTTNews | 682 days ago
Swiss Market Ends Flat After Choppy Ride

Swiss Market Ends Flat After Choppy Ride

The Switzerland stock market recovered after a weak start Monday morning, but faltered after a brief spell in positive territory. However, with select counters attracting buyers past mid afternoon, regained lost ground and ended the day's session flat.
RTTNews | 683 days ago
more news
Euro Slides Against Majors

Euro Slides Against Majors

The euro fell against its major counterparts in the New York session on Monday.
RTTNews | 683 days ago
Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Monday that its collaboration partner in Japan, Kyowa Kirin Co., Ltd., has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the New Drug Application (NDA) for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor will be marketed with the brand name PHOZEVEL in Japan.
RTTNews | 683 days ago
U.S. Dollar Climbs In Cautious Trade

U.S. Dollar Climbs In Cautious Trade

The U.S. dollar was higher in the European session on Monday, amid the Federal Reserve's stance of higher-for-longer interest rates and concerns about the property market in China.
RTTNews | 683 days ago
Jasper Therapeutics Appoints Herb Cross As New CFO

Jasper Therapeutics Appoints Herb Cross As New CFO

Biotechnology company Jasper Therapeutics, Inc. (JSPR) announced Monday the appointment of Herb Cross, an experienced senior financial executive, as the company's Chief Financial Officer (CFO).
RTTNews | 683 days ago

Stay up to date!

Add Ziņas to your browser

Extension Picture